David Horovitz

University of Rochester Medical Center

Papers

3

Total Citations

88

H-Index

3

About

David Horovitz is a leading urologic surgeon and researcher whose work centers on optimizing surgical approaches for robot-assisted radical prostatectomy (RARP), particularly in complex patient populations. His major contributions lie in comparing extraperitoneal (eRARP) and transperitoneal (tRARP) techniques to improve postoperative outcomes. In his highly cited 2017 study (42 citations), Horovitz demonstrated that the transperitoneal approach significantly reduces the rate of symptomatic lymphocele formation, a common and painful complication, by leveraging the peritoneum’s natural absorptive capacity. He further advanced surgical decision-making by showing that eRARP is safe and effective in patients with prior abdominal or pelvic surgery (28 citations) and those with previous inguinal hernia repair with mesh (18 citations), challenging traditional concerns about adhesions and mesh interference. His work provides evidence-based guidance for tailoring surgical access to individual patient histories, reducing complications and improving recovery. Horovitz’s research has been instrumental in refining RARP protocols, earning him recognition as a key contributor to minimally invasive urologic oncology.

Research Focus

Key Achievements

3
H-Index
3
Papers
88
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Rate of Symptomatic Lymphocele Formation After Extraperitoneal <i>vs</i> Transperitoneal Robot-Assisted Radical Prostatectomy and Bilateral Pelvic Lymphadenectomy
42 citations · 2017
📈 Most Prolific Year: 2017 (3 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of Rochester Medical Center

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago